Amy Bunch, APRN
Acute Care · Spartanburg, SCNPI 1568179497
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.6% of the total across 168 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 7.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,963 and has fallen 90.5% since, to $187 in 2025.
Across 168 payments — averaging $21.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$283
- Incyte Corporation$276
- Eisai Inc.$275
- Johnson & Johnson$265
- Merck$229
- Bristol Myers Squibb$215
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,22891%
- Education$3369%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $283 |
| Incyte Corporation | 8 | $276 |
| Eisai Inc. | 13 | $275 |
| Johnson & Johnson(2 entities) | 10 | $265 |
| Merck | 11 | $229 |
| Bristol Myers Squibb | 13 | $215 |
| Daiichi Sankyo Inc. | 6 | $184 |
| Novartis | 7 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $155 |
| AstraZeneca(2 entities) | 8 | $134 |
| Pfizer | 6 | $99 |
| Seagen Inc. | 6 | $96 |
| Exelixis Inc. | 5 | $87 |
| Jazz Pharmaceuticals Inc. | 4 | $84 |
| Lilly USA, LLC | 4 | $81 |
| Amgen | 4 | $81 |
| Ipsen Biopharmaceuticals, Inc | 4 | $76 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $75 |
| Servier Pharmaceuticals LLC | 3 | $63 |
| GSK | 3 | $55 |
| Beigene USA, Inc. | 3 | $55 |
| Gilead | 2 | $54 |
| Mirati Therapeutics, Inc. | 2 | $49 |
| Pharmaessentia USA Corporation | 2 | $48 |
| Karyopharm Therapeutics Inc. | 3 | $48 |
| Adaptive Biotechnologies Corporation | 2 | $37 |
| Exact Sciences | 2 | $37 |
| Sobi, Inc | 2 | $34 |
| EMD Serono, Inc. | 2 | $30 |
| Kyowa Kirin, Inc. | 2 | $29 |
| Acrotech Biopharma Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Bayer | 1 | $22 |
| CTI Biopharma Corp. | 1 | $22 |
| G1 Therapeutics, Inc. | 1 | $21 |
| Deciphera Pharmaceuticals Inc. | 1 | $19 |
| Novo Nordisk | 1 | $14 |
How this compares
$3,564 in reported general payments places this provider in the 85th percentile of 339 acute care providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $325 |
| Fluticasone Propionate | 17 | $148 |
| Doxycycline Hyclate | 19 | $139 |
| Methylprednisolone | 24 | $138 |
| Ondansetron OdtOndansetron | 20 | $126 |
| Hydroxyzine Hcl | 12 | $110 |
| Azithromycin | 16 | $62 |
| Prednisone | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Other acute care in Spartanburg
- Angela CaudillSpartanburg$5K
- Elizabeth BrannonSpartanburg$3K
- Heather BowersGreenville$94K
- Michael GajewskiColumbia$62K
- Heather NortonMt Pleasant$57K
- Cameron ThomassonSumter$28K
- Sarah MatthewsGreenville$28K
- Micheal BungerColumbia$15K
- Robin TrauflerColumbia$12K
- Susan FunkGreenville$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.